Abstract
Objects
The protein 300 (p300) and p300/CBP-binding protein-associated factor (PCAF) are enzymes with histone acetyltransferase (HAT) activity, a function that can become deregulated in different tumors and affect biological responses.
Methods
Due to the lack of information on the deregulation of these HATs in pediatric tumors, this study evaluated the expression of both the mRNA and proteins of p300 and PCAF in 54 samples of pediatric astrocytomas embedded in paraffin.
Results
PCAF was not expressed in normal brain tissue. In grade I tumors, the expression of p300 (1.1 ± 0.1) and PCAF (1.2 ± 0.11) was greater than those observed in grade III tumors: 0.72 ± 0.15 for p300 and 0.55 ± 0.11 for PCAF, and grade IV tumors: 0.74 ± 0.13 for p300 and 0.55 ± 0.13 for PCAF (p < 0.05). Immunohistochemical staining revealed the same tendency towards a decrease in the expression of the protein as the degree of clinical severity increased. Patients with recurrent grades I, III, and IV tumors had the highest levels of PCAF, compared to those who showed no recurrence (p < 0.05).
Conclusions
This work describes and confirms that these HATs play important roles in regulating genes and in the biological behavior of pediatric astrocytomas.
Similar content being viewed by others
References
Davis PK, Brackmann RK (2003) Chromatin remodeling and cancer. Cancer Biol Ther 2:22–29
Hake SB, Xiao A, Allis CD (2004) Linking the epigenetic "language" of covalent histone modifications to cancer. Br J Cancer 90:761–769
Brown KE (2003) Chromatin folding and gene expression: new tools to reveal the spatial organization of genes. Chromosome Res 11:423–433
Chan HM, La Thange NB (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114:2363–2373
Suganuma T, Kawabata M, Oshima T, Ikeda M-A (2002) Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator. Proc Natl Acad Sci USA 99:13073–13078
Zhu Y, Parada LF (2002) The molecular and genetic basis of neurological tumors. Nature Rev Cancer 2:616–626
Ozdag H, Teschendorff AE, Ahmed AA, Hyland SJ, Blenkiron C, Bobrow L, Veerakumarasivam A, Burtt G, Subkhankulova T, Arends MJ, Collins VP, Bowtel D, Kouzarides T, Brenton JD, Caldas C (2006) Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics 7:1–46
Roth SY, Denu JM, Allis CD (2001) Histone acetyltransferases. Annu Rev Biochem 70:81–120
Schiltz RL, Nakatani Y (2000) The PCAF acetylase complex as a potential tumor suppressor. Biochem Biophys Acta 1470:M37–M53
Armas-Pineda C, Arenas-Huertero F, Pérezpeña-Diazconti M, Chico-Ponce de León F, Sosa-Sáinz G, Lezama P, Recillas-Targa F (2007) Expression of PCAF, p300 and Gcn5 and more highly acetylated histone H4 in pediatric tumors. J Exp Clin Cancer Res 26:269–276
Rouaux C, Jokic N, Mbebi C, Boutillier S, Loefer J-P, Boutillier A-L (2003) Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 22:6537–6549
Li J, Guan H-Y, Gong L-Y, Song L-B, Zhang N, Wu J, Yuan J, Zheng Y-J, Huang Z-S, Li M (2008) Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res 14:6996–7003
Zeng WF, Navaratne K, Prayson RA, Weil RJ (2007) Aurora B expression correlates with aggressive behavior in glioblastoma multiforme. J Clin Pathol 60:218–221
Acknowledgments
The authors are grateful for the financial support provided by the Dirección de Investigación at the Hospital Infantil de México Federico Gómez (HIM/2007/020) and the Fundación Río Arronte.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eguía-Aguilar, P., Solís-Paredes, M., Reyes-Cid, P. et al. Expression of histone acetylases p300 and PCAF in pediatric astrocytomas. Childs Nerv Syst 29, 1089–1096 (2013). https://doi.org/10.1007/s00381-013-2046-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-013-2046-3